CD8A and neoplasm: To further assess the anti-tumor immunity of memory CD8+ T cells derived from NIH3T3-CM-educated CTLs responding to tumors, OT-1 CTLs generated in the presence or absence of NIH3T3-CM were transferred to B6 WT mice.